von Wyl V, Benkert P, Moser A, Lorscheider J, et al. Disability progression in relapse-free multiple sclerosis patients on fingolimod versus interferon-beta/glatiramer acetate. Mult Scler 2020 May 28:1352458520918489. doi: 10.1177/1352458520918489.
PMID: 32463336